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INTRODUCTION 
 
 
 
 
 
 
 
Introduction 
The indwelling urinary catheter plays an important part of many medical practices. 
The National Health Care Safety Network (NSHN) defined an indwelling catheter 
as any tube that is inserted into the urinary bladder through the urethra and does 
not include supra pubic catheters and nephrostomy tubes.
1
  
Catheter associated urinary tract infection (CAUTI) is the most common 
nosocomial infection worldwide accounting for nearly 30-40% of all institutionally 
acquired infections.
2-5
 80% of all urinary tract infections are associated with an 
indwelling catheter. It is defined by the Center for Disease Control (CDC) as any 
urinary tract infection in a patient who had an indwelling catheter in place at the 
time of or within 48 hours prior to onset of infection.
1
 There has not been any 
minimum period defined for the catheter to be in place for the urinary tract 
infection to be categorized as CAUTI. 
CAUTI can range from asymptomatic bacteremic urinary tract infection to 
symptomatic urinary tract infection. CAUTI is associated with major morbidity 
and can lead to genitourinary complications such as pyelonephritis, cystitis, 
prostatitis, epididymo-orchitis and other systemic complications such as vertebral 
osteomyelitis, septic arthritis, endocarditis, endophthalmitis and meningitis. 3% of 
all patients with catheter will develop bacteremia.  Complications associated with 
CAUTI lead to prolonged hospital stay, and increased cost, morbidity and 
mortality. The morbidity and mortality due to CAUTI according to Centre for 
Disease Control is increased by 2.8 fold and the length of hospitalization is 
increased by 1-3 days. The importance of CAUTI with regards to cost is best 
shown by the CMS (Medicare) data in the United States that estimated the annual 
cost due to CAUTI was between $340 to $450 Million.
6, 7, 8, 9
   
Asymptomatic bacteriuria often precipitates antimicrobial therapy and CAUTI 
forms one among the largest etiologies of drug resistant nosocomial infection. 
Incidence of sterile urine converting to bacteriuria occurs at a rate of 3-10% per 
day. Although definitive indications for use of catheter have been identified, it is 
often over used in most hospitals.  
The role of indwelling catheter in urinary tract infections was first reported by 
Kass in 1957 
10
 and most studies were done in the 1970’s and 1980’s to understand 
the pathogenesis of CAUTI. But in this modern era with improved health care, 
innovative technologies and early discharge of patients CAUTI still forms the bulk 
of nosocomial infections.  
Understanding the risk factors for catheter associated urinary tract infection is 
essential for implementing prevention strategies in daily care of our patients. This 
study aims to evaluate the patient and catheter related factors contributing to the 
urinary tract infection to help in decreasing the burden of hospital acquired 
infections.        
  
 
 
 
AIM OF THE STUDY 
 
 
 
 
 
 
 
Aim of the study 
To study the incidence of catheter associated urinary tract infection in our medical 
college hospital. 
To study the various risk factors predisposing to catheter associated urinary tract 
infection.  
To document the microbiological profile of catheter associated urinary tract 
infections.  
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
REVIEW OF LITERATURE 
 
 
 
 
 
 
 
Review of literature 
Catheters have been used from time immemorial. The word catheter is a Greek 
word meaning “to let or send down”. Catheters were used as early as 3000 B.C to 
relieve acute urinary retention.
11
 Materials used to form hollow tubes ranged from 
straw used by Syrians, rolled up palm leaves, hollow tops of onions used by 
Chinese and various metal tubes such as gold, silver, copper, brass and lead used 
by Hindus and Greeks. Silver became popular as a base for catheters as it could be 
moulded into various shapes and was proposed to also have anti septic effect. 
This property of silver for catheters was first used by Sir Benjamin Franklin in 
1752 for his older brother who suffered from kidney stones and needed to insert a 
bulky metal catheter into his bladder. With his local silversmith he designed a 
catheter with side holes bored into the tube to allow for drainage.
11
     
Straight catheters initially developed were difficult to introduce and hence curved 
tip catheters were developed. Coude’ with single bend and double Coude’ catheters 
with two bends at the tip were then developed in the 18
th
 and 19
th
 century for male 
catheterization.
12,13
 Catheters made from rubber were then developed but the initial 
catheters were weak at body temperature and left a lot of debris in the bladder. The 
discovery of rubber vulcanization by Goodyear in the year 1844 revolutionized the 
rubber industry by improving the firmness and durability of rubber catheters. This 
discovery allowed for mass production of rubber catheters. The earlier catheters 
were winged tips called Malecots or with flexible shoulders called Pezzer that had 
the property of self retaining in the bladder. 
Latex rubber catheters became available since the 1930s and the break through 
invention came from Dr Fredrik E B Foley, a Urologist from Minneapolis, who 
developed the latex balloon catheter. Advantage of this catheter was that the 
catheter could be retained within the bladder without having to suture or bandage 
the catheter to the external genitalia. The modern day catheter is named after this 
pioneer in urology though he lost the patent to the industrial firm C R Bard. 
The external diameter of the catheter was described using Charriere’s French scale 
and the term “French” was coined. Joseph Frederic Benoit Charriere was a maker 
of surgical instruments and in some French speaking countries the term Charriere 
(Ch) is still used. 
Concept of asepsis was first described by Joseph Lister in 1867. The incidence of 
infections reduced markedly using these aseptic principles and catheterization was 
deemed safe and acceptable. Dr Jack Lapides
14
 introduced the term clean 
intermittent catheterization in 1971 and he proposed that apart from bacteria, 
chronic residual stagnant urine and over distention of bladder were also responsible 
for urinary tract infections. Though initially scorned by urologist world over, CIC 
has become the method of choice to treat chronic retention of urine as in 
neurogenic bladders. 
The most common type of catheter used is the self retaining balloon Foley catheter. 
Other types of catheters in use include the DePezzer or mushroom catheter that are 
used for supra pubic catheterization. Catheters with triple lumen are used following 
surgeries on the prostate and bladder where continuous bladder irrigation is 
required. Fenestrated catheters allow drainage of the urethral secretions and reduce 
urethral inflammation, thereby decreasing the rates of strictures. The Tiemann 
coude catheter is used for continuous or intermittent use, has a curved tip with 
more than one opening for drainage and helps to negotiate the posterior urethra in 
patients with a large prostate. Whistle tipped catheter have larger openings above 
and lateral to the balloon and facilitate greater drainage. The Roberts catheter has 
openings proximal and distal to the balloon that facilitate the emptying of any 
residual urine in the bladder.
13, 15, 16, 17 
Urinary tract catheterization is one of the most frequently performed procedures in 
hospitals today and indications for catheterization may vary from acute retention of 
urine to simple monitoring of output in critically ill patients. Indications may be for 
diagnostic or therapeutic purposes. Diagnostic indications include obtaining 
sample of urine for evaluation, bladder distention prior to transvaginal or 
abdominal ultrasound of the pelvis, as part of cystogram or cystourethrogram and 
in critically ill patients for monitoring the urine output. Therapeutic indications 
include acute or chronic retention of urine, postoperatively following surgery or 
anaesthesia and instillation of chemotherapeutic agents.
18 
Hospital acquired infection is defined by the CDC
1
 as a localized or systemic 
condition resulting from an adverse reaction to the presence of  an infectious agent 
or toxin that occurs in a health care setting and was not present or incubating at the 
time of admission. Urinary tract infections account for 30% of all HAIs. 80% of 
the UTIs in this setting are estimated to be catheter associated. CAUTI also is 
second most common cause of hospital acquired blood stream infection. 
Nosocomial bacteruria and candiduria occur in upto 25% of patients catheterized 
for more than 7 days. Although most CAUTIs are asymptomatic and rarely extend 
hospital stay, they often lead to unnecessary antimicrobial drug therapy and 
thereby form the majority of nosocomial antibiotic resistant strains of organisms. 
 
 
 
 
 
 
 
 
Pathogenesis of CAUTI: 
Lifecycle of a catheter begins with catheter placement, continues when the catheter 
is kept in place, and ceases when the catheter is removed. It resumes if another 
catheter is re-inserted. Each stage of this cycle provides an opportunity for 
microorganisms to infect the urinary tract.
19
 Most organisms causing endemic 
CAUTI are derived from the patient’s own flora from the colon or perineum or 
from healthcare professionals handling during catheterization. Organisms can gain 
access through two routes. Direct inoculation at the time of catheter insertion leads 
to early extra-luminal contamination. Late contamination can occur from 
organisms that ascend from the perineum by capillary action in the pericatheter 
region through the thin mucous film. Intraluminal contamination occurs from 
organisms gaining access to the lumen of the catheter by breach in the system of 
closed drainage or by contamination of the urine collected in the collecting 
bag.
20,21,22 
The catheter provides a survival advantage to the bacteria. Bacteria adherent to the 
catheter are not washed away by the normal urine flow, are more resistant to 
phagocytosis, are multi drug resistant. Catheter provides a direct communication 
between the heavily colonized perineum and the bladder. The stagnated urine in 
the bladder or in the catheter also helps in promoting growth of the bacteria. In the 
absence of antimicrobial therapy, bacteruria develops within 24 to 48 hours. 
A study of the pathogenesis of CAUTI by Tambyah PA et al.
20
 concluded that 
CAUTIs occur in 66% of the patients by the extraluminal route and in 34% by the 
intraluminal route. The mechanism of CAUTI was based on a prospective study on 
1497 patients who were recently catheterized. 235 patients had a urinary tract 
infection. Gram negative organisms were the most common cause of CAUTI 
through both mechanisms. The study result also revealed candiduria to be more 
common via extraluminal route than intraluminal route (69% vs 31%).   
Most infected urinary catheters are enclosed by a thick biofilm layer that contain 
the organisms within the matrix of host proteins. Biofilms are communities of 
bacteria covered in a matrix of polysaccharides that facilitate adhesion.  The 
biofilm can form extraluminally, intraluminally or by a combination of both 
mechanisms. The infection usually advances in a retrograde fashion. But various 
studies have not clearly shown the role of  biofilm contributing to the CAUTI. 
Urinary catheters cause damage to the protective uroepithelial mucosa leading to 
the exposure of new binding sites for bacterial adhesions and also disrupt normal 
host mechanical defenses. The foreign body within the urinary tract helps the 
organisms to colonize with fewer virulence factors and establish infection when 
compared to pathogens to infect a fully functional urinary tract. Catheter 
obstruction can lead to sepsis and even mortality.    
 
Diagnosis of CAUTI: 
Catheter associated urinary tract infection manifests as either symptomatic urinary 
tract infection or asymptomatic bacteremic bacteruria. The Center for Disease 
Control has developed a classification system for diagnosis of CAUTI based on 
fixed criteria. 
Symptomatic CAUTI is defined by the presence of catheter at the time of specimen 
collection or the catheter should have been removed within 48 hrs prior to 
specimen collection with atleast one of the signs and symptoms such as fever   38    
Centigrade), suprapubic pain or costovertebral angle pain or tenderness with a 
positive urine culture of >10
5
 colony forming units/ml with no more than 2 species 
of microorganisms. If urine culture reveals colony count between >10
3
 and ≤ 105 
CFU then a positive dipstick test for leukocyte esterase and / or Nitrate, pyuria  ( 
urine specimen with ≥10 white blood cells [WBC] /mm3 of unspun urine or ≥3 
WBC/high power field of spun urine) and presence of bacteria on gram stain of 
unspun urine is also diagnostic of CAUTI. 
In asymptomatic bacteremic urinary tract infections patient has no signs or 
symptoms of UTI, but has a positive urine culture with >10
5 
colony forming units 
of no more than 2 micro organisms with a positive blood culture showing atleast 
one matching uropathogen. The CDC in 2009 updated the definitions for UTI and 
removed isolated asymptomatic bacteriuria without symptoms or positive urine 
analysis from the surveillance criteria of urinary tract infections.  
Urinary catheter tip culture sensitivity is not accepted as diagnosis of catheter 
associated urinary tract infections. Similarly urine cultures from bag specimens are 
not reliable. Specimen from indwelling catheters should be obtained after 
disinfecting the sampling port. Urine specimens should be cultured as soon as 
possible preferably within 1 to 2 hours. If urinary specimens cannot be inoculated 
within 30 minutes, the sample should be refrigerated or transported in appropriate 
solutions. Specimens that have been refrigerated should be inoculated within 24 
hours.   
Other key term defined by the CDC is location of attribution. This is the location 
(such as ward, casualty, ICU and so on) where the patient was assigned on the date 
of the UTI event and is further defined as the date when the first clinical evidence 
appeared or the date the specimen used to meet the criterion was collected, 
whichever came first. The date on which the specimen was collected is known as 
the event date. 
 
 
 
 
Risk factors for CAUTI: 
Various studies have attempted to study the risk factors associated with CAUTI. 
The risk factors are classified as catheter related, patient related factors and 
environment or personnel related factors. 
Catheter related factors include duration of catheterization, lack of urimeter 
drainage, colonization of drainage bag, reason for catheterization and breaks in 
closed system. Patient related factors include age, gender, critically ill, presence of 
Diabetes, renal failure and periurethral colonization. Environment or personnel 
related factors include department in which patient is hospitalized, day of insertion 
of catheter in hospital, catheterization outside the operation theatre, lack of 
antibiotics and improper care. 
Tambyah PA et al.
20
 published a comprehensive review of catheter associated 
urinary tract infections with respect to pathogenesis, risk factors, clinical and 
laboratory features and contribution to hospital costs, morbidity and mortality. 
1,497 newly catheterized patients hospitalized at the University of Wisconsin 
Hospitals and Clinics were prospectively studied. Majority of infections (2/3
rd
) 
were caused by organisms by extraluminal mechanism. Most common organism 
were Staphylococci, Enterococci and yeasts that are commonly present in the 
perineum as commensals. For intra-luminal route, Gram-negative bacteriae  
(Enterobacter, Pseudomonas, Acinetobacter) were the most common organisms 
grown. Prolonged catheterization and female gender were the most important risk 
factors. Other risk factors identified were catheterization outside the operating 
theatre, diabetes, concurrent infections, malnutrition and renal failure.  
The factors influencing bacteriuria following urethral catheterization were studied 
by Garibaldi RA et al.
23
 as early as in 1974. 405 patients were included in the 
study. 23% acquired bacteriuria and risk was significantly greater in females, 
elderly or critically ill. The protective effect of antimicrobials was limited only to 
the first 4 days of catheterization. 
A comprehensive study of risk factors for CAUTI was done by Maki DG et al.
21
 
and published in 2000. The various risk factors reported in this study included 
prolonged duration of catheterization, female sex, catheter insertion outside the 
operating room, other active sites of infection, diabetes, anemia, malnutrition, 
presence of ureteral stents, indication for catheterization being urine output 
monitoring and violation in the closed system of drainage. The study concluded 
that duration of catheterization is the single most important risk factor for CAUTI. 
Platt R et al.
24
 conducted a prospective study between June 1979 to April 1981at 
New England Hospital, Boston, Massachusetts. 134 of 1,458 patients developed a 
urinary tract infection due to indwelling catheters. The indication for catherization 
was also found to be a risk factor for CAUTI apart from the above mentioned risk 
factors. 
Boybeyi O et al.
25
 studied the risk factors for CAUTI in paediatric patients 
undergoing surgery. 112 patients were included in this study. All patients had 
serial urine cultures done. Patients with positive urine cultures were catheterized 
for longer duration. The duration of preoperative antibiotic usage had a significant 
association with increased risk of CAUTI (P = 0.003). The rate of infection in 
patients catheterized outside the operating room was significantly higher (P = 
0.030). 
 This study concluded that increased duration of catheterization, preoperative 
antibiotic usage and inappropriate conditions during catheterization were the most 
important risk factors for development of CAUTI.      
Temiz E et al.
26
 conducted a study in Turkey on factors associated with CAUTI 
and effects of other simultaneously existing nosocomial infections in an intensive 
care unit setting. They studied 204 patients out of which 85 developed a 
nosocomial infection. 22 patients developed CAUTI alone whereas 38 developed 
CAUTI with an additional nosocomial infection. The other infection was acquired 
either concomitantly or prior to the onset of CAUTI. This study revealed that in the 
presence of concomitant nosocomial infection at other sites, immune suppression, 
history of previous antibiotic usage were independent factors associated with risk 
of CAUTI. When nosocomial infections at other sites were excluded female gender 
and duration of catheterization were the significant risk factors. 
 A review article was published by Parida S, Mishra SK
27
 on urinary tract 
infections in the critical care unit. They conducted a medline search for factors 
influencing urinary tract infections and their management. Prolonged 
catheterization, female gender, diabetes, raised renal parameters, presence of stent 
were all independent risk factors for CAUTI.  
Tsuchidaa T et al.
28
 studied the relationship between catheter care and the risk of 
CAUTI in Japanese general hospitals. They included 555 adult patients who were 
catheterized for more than 3 days in five general hospitals in Japan. The data 
collected included catheter insertion method, catheter management and signs and 
symptoms of urinary tract infections. The mean duration of catheterization was 25 
days and the incidence of CAUTI ranged from 0.6 to 7.2 cases per 1000 device 
days. 94% of the patients diagnosed with CAUTI had fecal incontinence and hence 
only this group was analyzed.  They concluded that the use of closed system of 
catheter drainage and cleansing of the perineal area daily reduced the incidence of 
CAUTIs by 50%. 
Wald HL et al.
29
 in 2008, as part of National Surgical Infection prevention project 
published an analysis of indwelling catheter use in the post operative period. 35904 
medicare patients undergoing major surgery were included in the study. 86% of 
patients had perioperative indwelling urinary catheters and 50% were catheterized 
for more than 2 days in the postoperative period. Duration of postoperative 
catheterization longer than 2 days was associated with an increased risk of 
nosocomial urinary tract infection.  
Bhatia N et al.
30
 published an article on urinary catheterization in medical wards. 
They studied the indications for catheterization in medical wards, the rate of 
inappropriate catheterization and their risk factors, CAUTI and colonization of 
bacteria on Foleys catheter. This hospital based prospective study included 125 
patients admitted in medical wards. 28.8% of patients in this study were 
inappropriately catheterized and the most frequent indication for inappropriate 
catheterization was urinary incontinence without significant skin break down. 
22.4% patients developed CAUTI and the risk factors for acquiring CAUTI were 
age >60 years, impaired mental status and duration of catheterization >3 days. 
Adukauskiene et al.
31
 studied the etiology, risk factors and outcome of urinary tract 
infections in 82 patients admitted to an ICU. All patients in this study with a 
positive urinary culture had a catheter in place. Risk of development of urinary 
tract infection estimated in this study was 21.7% for each day of catheterization. 
But in contrast to many other studies this study did not find a significant 
correlation between age, sex and duration of catheterization alone on the 
occurrence of urinary tract infection. 
Lee JH et al.
32
 undertook a retrospective study to investigate the factors associated 
with nosocomial catheter associated urinary tract infections in intensive care units 
over 2 years at a single centre in South Korea. 1315 patients were included in the 
study between January 2009 to December 2010. CAUTI was defined as isolated 
bacterial growth of  >10
5
 CFU within 48 hours after transfer to the ICU if the 
catheter was placed before the transfer or 48 hours after insertion if the catheter 
was inserted in the ICU. Only patients with negative initial culture results before 
catheterization were included in the study. Using the above criteria 241 patients 
had a positive urine culture and 61 patients were diagnosed with CAUTI. Diabetic 
patients were found to have a relative risk of 4.55 for developing CAUTI and also 
had 1.1 fold increased duration of indwelling catheters. E.coli was the most 
common organism cultured in 38.7% patients.  
Mohammedzadeh M and Behnaz F
33
 studied the incidence and risk factors for 
CAUTI in Iran. The variables studied were sex, age, antimicrobial usage, duration 
of catheterization and hospital stay. The incidence of CAUTI in this study was 
21.8%. Duration of catheterization had a relative risk of 1.2 whereas antimicrobial 
usage was found to be protective.   
Domingo KB, Mendoza MT and Torres TT
34
 conducted a prospective study in 
1998 to determine the incidence of CAUTI, risk factors associated and the 
pathogens isolated with their resistance patterns. Serial urine cultures were done 
until development of catheter related urinary tract symptoms, catheter removal or 
discharge. The incidence of CAUTI in this study was 51.4%. Majority (91%) 
acquired infection within seven days of catheterization. Most common organism 
grown was Escherichia coli. Three risk factors were found to be significantly 
associated with CAUTI that included duration of catheterization, female gender 
and diabetes. They concluded that since duration of catheterization was the only 
alterable risk factor, importance must be laid on reducing the catheter duration to a 
minimum period. 
Jeong et al.
35
 compared the catheter associated urinary tract infection rates 
following the use of four different perineal care agents (skin cleansing foam, soap-
and-water, 10% povidone-iodine and normal saline) among patients in an intensive 
care setting. 97 patients were included in the study. Patients were randomized to 
receive any one of the four different types of perineal care. They concluded that the 
type of perineal care did not influence the incidence of CAUTIs.  
Jaggi N and Sissodia P
36
 conducted a programme of multimodal supervision to 
reduce CAUTI at a tertiary hospital between January 2009 to December 2009. 
They initially analyzed CAUTI rates for the first 6 months and then instituted a 
supervision program from the month of July. The program included training with 
respect to standard protocols for sample collection, urinary catheter care check list 
and hand hygiene practices. The average rate of CAUTI decreased by almost 47% 
after the program. The average duration of catheterization reduced from 23 days to 
21 days. The adherence to strict catheter care check list and hand hygiene 
compliance was increased by 44% and 56% respectively. Factors such as bladder 
irrigation and perineal cleansing were not found to significantly affect CAUTI 
rates. 
Similar study was conducted by Rosenthal VD, Guzman S and Safdar N
37
 in 
Argentina. Simple factors such as prevention of compression of the tubing by the 
leg and proper hand washing by nurses and health care professionals improved the 
CAUTI rates that decreased significantly from 21.3 to 12.39 per 1000 catheter-
days. They concluded that implementing education and performance feedback 
regarding trivial but essential points such as catheter care measures and compliance 
with hand washing prior to catheterization could significantly reduce CAUTI rates.  
Huth et al.
38
 in 1992 conducted a clinical trial of junction seals to prevent urinary 
catheter associated urinary tract infection. The study included patients attending a 
community hospital. They were randomized into two groups within 24 hours of 
insertion of catheter to receive a tape seal applied to the catheter-drainage tube 
junction or no tape seal. The catheter urine cultures and violations in catheter care 
were monitored until patient discharge or catheter removal. 13.7% of 903 patients 
in the junction seal group acquired bacteriuria compared with 14.9% of 837 
patients in the control group. Multivariate analysis was done and only female 
gender and lack of systemic antibiotic use correlated significantly with 
development of bacteriuria. The junction treatment randomization showed no 
significant differences between the treatment groups. 
Danchaivijitr S et al.
39
 published a study in 2005 reporting the incidence, risk 
factors and cost factor analysis of catheter associated urinary tract infections in 
patients with indwelling catheters for more than a week. 101 patients were 
included in this study. Incidence of CAUTI was 73.3% and higher incidence was 
seen in the first two weeks of catheterization. None of the patients had secondary 
bacteremia. High incidence of resistant organisms were found in this study. 
Significant risk factors were prolonged catheterization and change of catheter. 
This study is being done to describe the complication of urethral catheterization in 
terms of the incidence of CAUTI, the microbiological profile and to determine the 
significance of various risk factors involved.   
 
 
 
 
 
 
 
 
  
 
 
 
MATERIAL AND METHODS 
 
 
 
 
 
 
 
Material and Methods 
Type of study: Prospective study 
Period of study: September 2012 to February 2014 
Inclusion criteria: 
A total of 210 patients subjected to Foleys catheterisation in the hospital (or within 
24 hours of presentation to the hospital) for an appropriate indication were 
included in the study. 
Exclusion criteria: 
The following patients were excluded from the study. 
 Pregnant women 
 Patients with known allergy to latex or silicone 
 Patients with urethral catheter in place for >24 hours  at admission 
 Subjects whose initial urine culture at onset of catheterization was already 
positive 
 Patients with suprapubic catheters  
The study was approved by the institutional ethical committee.   
 
 
 
On entry into the study, demographic and clinical data including age, gender,  
underlying systemic diseases including diabetes mellitus and cancer, 
immunosuppressive therapy, recent surgery and the indication for catheterization 
was recorded. Urine culture was done at the time of catheterization, 48 hours after 
catheterization and when the patient had symptoms of fever, supra pubic pain, loin 
pain or change in colour of urine. Samples were also sent on the day of catheter 
removal in all patients. The duration of catheterization was recorded as the date 
when symptoms appeared or when the urine specimen was sent for culture 
sensitivity, whichever was earlier. Haemoglobin and renal function tests were sent 
on the day of admission.   
Approximately 3ml of urine was aspirated from the sampling port of the catheter 
after sterilizing the port with 10% povidone iodine. Each sample was immediately 
sent to the microbiology laboratory for inoculation into agar plates. Quantitative 
analysis for the growth and type of organisms were monitored at 24 and 48 hours. 
Antibiotic susceptibility testing was done using the Kirby-Bauer disk diffusion 
technique.  
 
 
 
 
  
 
 
 
OBSERVATION AND RESULTS 
 
 
 
 
 
 
 
Observation and Results 
Statistical analysis: Data were analyzed using the statistical analysis package 
SPSS version 20 for Windows and MEDCALC software. Two analyses were 
undertaken: univariate analyses of the association of each variable with CAUTI 
and multivariable logistic regression to predict CAUTI outcome. In the univariate 
analysis, Chi-square test and Fisher’s Exact Test was used for categorical variables 
and Student’s t-test or Mann-Whitney test was used for continuous variables. All 
testing was two-sided. Univariate relative risk ratios and multivariable analyses 
were done by assigning the continuous variables into discrete variables, based on 
their being above or below a set value. The Multivariable logistic analyses was 
done in a stepwise manner. One variable was entered at a time into the 
classification equation. The predictor variable with the highest association with 
CAUTI was first entered. Variables with a statistically significant contribution to 
CAUTI were then entered into the final model. 
Table 1: Descriptive Statistics 
 N Minimum Maximum Mean Std. Deviation 
Creatinine 210 .6000 4.2000 1.402381 .6017073 
Dur of  Cath 
catheterizatio
n 
210 2.00 12.00 4.85 2.346 
Hemoglobin 210 6.8000 13.6000 10.277143 1.3406602 
Age 210 17 88 51.61 16.213 
 
 
Table 2: Age Group Distribution 
 Frequency Percent Valid 
Percent 
Cumulative 
Percent 
Valid 
<20 4 1.9 1.9 1.9 
21-30 20 9.5 9.5 11.4 
31-40 39 18.6 18.6 30.0 
41-50 36 17.1 17.1 47.1 
51-60 37 17.6 17.6 64.8 
>60 74 35.2 35.2 100.0 
Total 210 100.0 100.0  
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Chart 1: Age group Distribution 
Number 
Table 3: Sex Distribution 
 
Frequency Percent Valid Percent 
Cumulative 
Percent 
Valid 
F 69 32.9 32.9 32.9 
M 141 67.1 67.1 100.0 
Total 210 100.0 100.0  
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Chart 2: Sex distribution 
Table 4: Catheter Size 
 
Frequency Percent Valid Percent 
Cumulative 
Percent 
Valid 
16 77 36.7 36.7 36.7 
18 126 60.0 60.0 96.7 
22 7 3.3 3.3 100.0 
Total 210 100.0 100.0  
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Chart 3: Catheter Size 
Table 5: Duration of catheterization 
 Frequency Percent Valid Percent Cumulative Percent 
 
2 21 10.0 10.0 10.0 
3 52 24.8 24.8 34.8 
4 57 27.1 27.1 61.9 
5 13 6.2 6.2 68.1 
6 15 7.1 7.1 75.2 
7 10 4.8 4.8 80.0 
8 24 11.4 11.4 91.4 
9 10 4.8 4.8 96.2 
10 4 1.9 1.9 98.1 
11 2 1.0 1.0 99.0 
12 2 1.0 1.0 100.0 
Total 210 100.0 100.0  
  
 Table 6: Frequency distribution of Creatinine  
 
 
Frequency Percent 
Valid 
Percent 
Cumulative Percent 
Valid 
<=1.5 163 77.6 77.6 77.6 
>1.5 47 22.4 22.4 100.0 
Total 210 100.0 100.0  
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 Table 7: Age group*CAUTI cross tabulation 
 CAUTI  Total 
Absent Present 
Age 
Group 
<20 
Count 3 1 4 
% within Age Group 75.0% 25.0% 100.0% 
% within CAUTI  2.5% 1.1% 1.9% 
% of Total 1.4% 0.5% 1.9% 
21-
30 
Count 17 3 20 
% within Age Group 85.0% 15.0% 100.0% 
% within CAUTI  14.2% 3.3% 9.5% 
% of Total 8.1% 1.4% 9.5% 
31-
40 
Count 33 6 39 
% within Age Group 84.6% 15.4% 100.0% 
% within CAUTI  27.5% 6.7% 18.6% 
% of Total 15.7% 2.9% 18.6% 
41-
50 
Count 28 8 36 
% within Age Group 77.8% 22.2% 100.0% 
% within CAUTI  23.3% 8.9% 17.1% 
% of Total 13.3% 3.8% 17.1% 
51-
60 
Count 15 22 37 
% within Age Group 40.5% 59.5% 100.0% 
% within CAUTI  12.5% 24.4% 17.6% 
% of Total 7.1% 10.5% 17.6% 
>60 
Count 24 50 74 
% within Age Group 32.4% 67.6% 100.0% 
% within CAUTI 
type 
20.0% 55.6% 35.2% 
% of Total 11.4% 23.8% 35.2% 
Total Count 120 90 210 
 
Chi-square test p value 0.000 
 
 
 
 
Table 8: Sex * CAUTI  
Crosstab 
   CAUTI  
   Absent Present Total 
Sex F Count 37 32 69 
% within CAUTI 30.8% 35.6% 32.9% 
% of Total 17.6% 15.2% 32.9% 
M Count 83 58 141 
% within CAUTI 69.2% 64.4% 67.1% 
% of Total 39.5% 27.6% 67.1% 
 Total Count 120 90 210 
% within CAUTI 100.0% 100.0% 100.0% 
% of Total 57.1% 42.9% 100.0% 
Chi-Square test p value 0.471 
Chart 5: Sex*CAUTI 
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Table 9: Urinary retention * CAUTI  
Crosstab 
   CAUTI  
   Absent Present Total 
Urinary 
retention 
Absent Count 99 47 146 
% within CAUTI  82.5% 52.2% 69.5% 
% of Total 47.1% 22.4% 69.5% 
Present Count 21 43 64 
% within CAUTI  17.5% 47.8% 30.5% 
% of Total 10.0% 20.5% 30.5% 
 Total Count 120 90 210 
% within CAUTI  100.0% 100.0% 100.0% 
% of Total 57.1% 42.9% 100.0% 
Chi-Square p value 0.000 
Chart 6: Urinary retention*CAUTI  
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Table 10: Incontinence * CAUTI  
Crosstab 
 CAUTI  
Absent Present Total 
Incontinence Absent Count 116 73 189 
% within CAUTI  96.7% 81.1% 90.0% 
% of Total 55.2% 34.8% 90.0% 
Present Count 4 17 21 
% within CAUTI  3.3% 18.9% 10.0% 
% of Total 1.9% 8.1% 10.0% 
 Total Count 120 90 210 
 
Chi-Square P value 0.000 
 
 
 
 
 
 
Table 11: Diabetes * CAUTI  
Crosstab 
 CAUTI  
Absent Present Total 
Diabetes Absent Count 103 32 135 
% within CAUTI  85.8% 35.6% 64.3% 
% of Total 49.0% 15.2% 64.3% 
Present Count 17 58 75 
% within CAUTI  14.2% 64.4% 35.7% 
% of Total 8.1% 27.6% 35.7% 
 Total Count 120 90 210 
 
Chi-Square p value 0.000 
 
 
 
 
 
 
Table 12: Place of catheterization * CAUTI  
Crosstab 
 
 CAUTI  
 Absent Present Total 
Place of 
catheterization 
Casualty 
Count 3 26 29 
% within CAUTI 2.5% 28.9% 13.8% 
% of Total 1.4% 12.4% 13.8% 
OT 
Count 95 19 114 
% within CAUTI 79.2% 21.1% 54.3% 
% of Total 45.2% 9.0% 54.3% 
Ward 
Count 22 45 67 
% within CAUTI 18.3% 50.0% 31.9% 
% of Total 10.5% 21.4% 31.9% 
 Total Count 120 90 210 
Chi-Square p value 0.000 
 
 
 
 
Table 13: Drainage system * CAUTI 
Crosstab 
   CAUTI  
   Absent Present Total 
Drainage system Closed Count 100 21 121 
% within CAUTI 83.3% 23.3% 57.6% 
% of Total 47.6% 10.0% 57.6% 
Open Count 20 69 89 
% within CAUTI 16.7% 76.7% 42.4% 
% of Total 9.5% 32.9% 42.4% 
 Total Count 120 90 210 
% within CAUTI 100.0% 100.0% 100.0% 
% of Total 57.1% 42.9% 100.0% 
 
Chi-Square P value 0.000 
 
 
 
Table 14: Duration of Catheterization*CAUTI  
 CAUTI 
Total 
Absent Present 
DURCAT 
<=6 days 
Count 115 41 156 
% within CAUTI  95.8% 45.6% 74.3% 
% of Total 54.8% 19.5% 74.3% 
>6 days 
Count 5 49 54 
% within CAUTI  4.2% 54.4% 25.7% 
% of Total 2.4% 23.3% 25.7% 
Total 
Count 120 90 210 
% within CAUTI  100.0% 100.0% 100.0% 
% of Total 57.1% 42.9% 100.0% 
 
Chi-Square p value 0.000 
  
Table 15: Catheter Size * CAUTI  
 CAUTI 
Total 
Absent Present 
Catheter Size 
16 44 33 77 
18 63 63 126 
22 2 5 7 
Total 109 101 210 
 
Chi-Square p value 0.279 
 
 
 
 
 
 
 
 
 
 
 
Table 16: Hemoglobin * CAUTI  
Crosstab 
 CAUTI 
Total 
Absent Present 
Hb 
>=10 
Count 95 41 136 
% within CAUTI  79.2% 45.6% 64.8% 
% of Total 45.2% 19.5% 64.8% 
<10 
Count 25 49 74 
% within CAUTI  20.8% 54.4% 35.2% 
% of Total 11.9% 23.3% 35.2% 
Total 
Count 120 90 210 
% within CAUTI  100.0% 100.0% 100.0% 
% of Total 57.1% 42.9% 100.0% 
Chi-Square p value 0.000 
 
 
 
 
 
Table 17: Creatinine * CAUTI 
Crosstab 
 CAUTI 
Total 
Absent Present 
Creatinine 
<=1.5 
Count 114 49 163 
% within CAUTI  95.0% 54.4% 77.6% 
% of Total 54.3% 23.3% 77.6% 
>1.5 
Count 6 41 47 
% within CAUTI 5.0% 45.6% 22.4% 
% of Total 2.9% 19.5% 22.4% 
Total 
Count 120 90 210 
% within CAUTI  100.0% 100.0% 100.0% 
% of Total 57.1% 42.9% 100.0% 
 
Chi-Square p value 0.000 
 
 
 
 
 
 Table 18: Micro organism profile 
 
Frequency Percent 
Valid 
Percent 
Cumulative 
Percent 
Valid 
Acinetobacter 3 1.4 1.4 1.4 
E.Coli 77 36.7 36.7 38.1 
Enterococcus 11 5.2 5.2 43.3 
Klebsiella 39 18.6 18.6 61.9 
no growth 63 30.0 30.0 91.9 
Proteus 5 2.4 2.4 94.3 
Pseudomonas 10 4.8 4.8 99.0 
Staph Aureus 2 1.0 1.0 100.0 
Total 210 100.0 100.0  
 
 
 
 
 
 
 
Chart 7: Microorganism profile 
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Logistic regression 
Coefficients and Standard Errors 
  Variable Coefficient Std. Error P 
Age -0.067851 0.024892 0.0064 
Catheter_Size 0.52484 0.21960 0.0168 
Diabetes 1.63283 0.60146 0.0066 
Drainage_system 2.31897 0.52399 <0.0001 
Duration_of_catheterisation 0.94343 0.18882 <0.0001 
Place_of_catheterisation=1 1.36890 0.78026 0.0794 
Sex=2 1.88000 0.65038 0.0038 
Constant -15.7110     
  Odds Ratios and 95% Confidence Intervals  
  Variable Odds ratio 95% CI 
Age 0.9344 0.8899 to 0.9811 
Catheter_Size 1.6902 1.0990 to 2.5993 
Diabetes 5.1183 1.5746 to 16.6379 
Drainage_system 10.1652 3.6398 to 28.3889 
Duration_of_catheterisation 2.5688 1.7742 to 3.7193 
Place_of_catheterisation=1 3.9310 0.8518 to 18.1415 
Sex=2 6.5535 1.8317 to 23.4470 
ROC curve analysis 
Area under the ROC curve (AUC)  
  
Area under the ROC curve (AUC)  
0.946944 
Standard Error
a
 0.0147 
95% Confidence interval
b
 0.907371 to 0.973082 
z statistic 30.468 
Significance level P (Area=0.5) <0.0001 
a
 DeLong et al., 1988 
b
 Binomial exact 
Chart 8: ROC curve 
 
LOGREGR_Pred2
0 20 40 60 80 100
0
20
40
60
80
100
100-Specificity
S
e
n
s
it
iv
it
y
 Sensitivity: 88.9
 Specificity: 88.3
 Criterion : >0.4281
Table 19: Summary of logistic regression analysis: 
 
Variables P value Odds 
ratio 
Std error 95% C.I 
Age 0.0064 0.9344 0.024892 0.8899 to 0.9811 
Catheter_Size 0.0168 1.6902 0.21960 1.0990 to 2.5993 
Diabetes 0.0066 5.1183 0.60146 1.5746 to 16.6379 
Drainage_system <0.0001 10.1652 0.52399 3.6398 to 28.3889 
Duration_of_catheterisation <0.0001 2.5688 0.18882 1.7742 to 3.7193 
Place_of_catheterisation=1 0.0794 3.9310 0.78026 0.8518 to 18.1415 
Sex=2 0.0038 6.5535 0.65038 1.8317 to 23.4470 
 
 
 
 
 
 
 
 
 
  
 
 
 
ANALYSIS 
 
 
 
 
 
 
 
Analysis 
210 patients were included in the study.  
Patients in this study were catheterized for a minimum period of 2 days to a 
maximum of 12 days and the mean duration of catheterization was 4.85 days 
(Table 1). 
The age of the patients varied from a minimum of 17 years to maximum of 88 
years (mean 51.61 years) (Table 2). 
Among 210 patients, 141 were males and 69 were female patients (Table 3).  
Three various sizes of catheters were used namely 16 Fr, 18 Fr and 22 Fr (Table 4).  
Most common indication for catheterization in this study was postoperative. 64 
patients were catheterized for retention of urine, 21 patients for incontinence and 
13 patients were catheterized for monitoring of urine output. 
Most common organism grown in culture was Escherichia coli (36.7%) followed 
by Klebsiella (18.6%) and pseudomonas. All the positive cultures were 
unimicrobial (Table 18).   
Results of univariate analysis done using SPSS software version 20 revealed the 
following. 
Sex of the patient was not significantly associated with risk of catheter associated 
urinary tract infection in this study (p value 0.471) when studied as an independent 
risk factor (Table 8). 
47.8% of 64 patients presenting with retention of urine developed urinary tract 
infection following catheterization which was significant as an independent 
variable (p value 0.000) (Table 9). 
21 patients were catheterized for incontinence and showed a significant correlation 
for development of CAUTI (p value 0.000) (Table 10). 
Diabetes was associated with a significantly increased risk of CAUTI (p value 
0.000) (Table 11).  
96 patients were catheterized outside the operation theatre which included patients 
catheterized in ward and casualty. Place of catheterization was a significant risk 
factor with maximum risk of CAUTI seen in patients catheterized outside the 
operation theatre (p value 0.000) (Table 12). 
89 patients had a breach in the closed system of drainage which was associated 
with significantly increased risk (p value 0.000) of CAUTI than in patients in with 
a closed drainage system (Table 13). 
54 patients in this study had a duration of catheterization of 7 or more days. 
Duration of catheterization more than 6 days had a significantly higher risk of 
CAUTI than in patients with duration of catheterization less than 6 days (p value 
0.000) (Table 14). 
Various catheter sizes were used with 18 Fr catheter being used most commonly in 
126 patients. Catheter size was not found to have a significant correlation with 
increased risk of CAUTI (p value 0.279) (Table 15). 
 74 patients in this study had a hemoglobin of less than 10 gm/dl. Patients with 
hemoglobin less than 10 had a significantly higher risk of CAUTI (p value 0.000) 
(Table 16).  
Raised renal parameters with serum creatinine more than 1.5 was seen in 47 of the 
210 patients studied. Patients with raised renal parameters had a significant 
correlation to development of CAUTI (p value 0.000) (Table 17). 
Model for multivariate analysis was done using logistic regression analysis to 
create an ROC curve (Chart 8).  
The most significant factors in this model were Age, catheter size, diabetes, 
duration of catheterization, a breach in the closed system of catheter drainage and 
sex. Drainage system and duration of catheterization were the most important 
factors (p value <0.001) (Table 19). The model derived has a sensitivity of 88.9% 
and a specificity of 88.3% in correctly predicting the risk of catheter associated 
urinary tract infection in patients when all the various risk factors are used. 
 
 
 
  
 
 
 
DISCUSSION 
 
 
 
 
 
 
 
Discussion 
Indwelling urinary catheters are a routine in most urological patients.  As with any 
medical innovation the benefits of the catheters must be weighed against its 
potential adverse effects. The most common adverse effect being catheter 
associated urinary tract infection.  
Studies by four different groups
20, 24, 40, 42
 have identified certain risk factors that 
were significantly associated with CAUTI. Factors that were found to be 
associated with an increased risk in one or more of the studies included prolonged 
duration of catheterization, female gender, renal insufficiency, diabetes, advancing 
age and catheter care violations. 
The incidence of CAUTI in our study was 42.9% and is comparable to studies 
done by Domingo et al. and Danchaivijitr S et al. who reported a CAUTI incidence 
of 51.4% and 73.3% respectively. Majority of the patients were catheterized in the 
operation theatre following surgery (54.3%), rest were catheterized in the ward 
(31.9%) and Casualty (13.8%). The criteria for CAUTI was taken as bacteriuria in 
the presence of symptoms (symptomatic UTI) 
as
 per the CDC criteria. CAUTI rates 
from other studies are variable as different criteria were used to define CAUTI.  
Microbiological profile in our study revealed Escherichia coli and other entero 
pathogens to be the most common pathogens. This has also been reported in 
various other studies.
2,3,4
 This study did not study the organisms infecting the 
urinary tract from extra luminal mechanisms wherein gram positive cocci like 
Staphylococcus aureus and Enterococcus were more common. 
Seven factors were independently predictive of an increased risk of catheter 
associated urinary tract infection. Age, duration of catheterization, diabetes, 
catheterization place, drainage type, anemia and raised renal parameters were 
found to be significant risk factors. Other factors such as sex of the patient (p value 
0.471) and catheter size (p value 0.279) were not found to be significant factors. 
The first study done to evaluate risk factors for CAUTI done by Garibaldi et al.
23
 in 
1974 revealed that catheter care violations like break in the drainage system was 
not associated with an increased risk . In the contrary other studies done by Maki 
DG et al.
21
 and Platt et al.
24
 concluded that catheter care violations formed an 
important risk factor for catheter associated urinary tract infections. This was also 
confirmed in this study.  
Seven factors were included in multivariate analysis as shown in the logistic 
regression table. Most significant risk factors for CAUTI were duration of 
catheterization and drainage system (p value <0.0001).  Female gender (OR 6.55) 
and Diabetes (OR 5.11) were associated with a significantly increased risk. Shorter 
urethra in females and its proximity to the perineum are factors determining an 
increased risk in females.  
Diabetics were consistently found to be associated with increased risk of CAUTI in 
all studies including this study. The possible explanation is that diabetics have an 
increased colonization of organisms in their perineum and urine in diabetics also 
supports the growth of microorganisms. Altered host immunity in diabetics may 
also play a role though yet to be investigated.  
Duration of catheterization was found to be a very significant risk factor with an 
odds ratio of 2.56. Most comprehensive study of risk factors for catheter associated 
urinary tract infection done by Maki DG and Tambyah PA 
21
 also revealed that 
longer duration of catheterization is associated with increased chance (OR 5.2) of 
ascending infections either intra or extraluminal. Catheter size and age were less 
significant factors in the logistic regression model with an odds ratio of 1.69 and 
0.93 respectively.  
The place of catheterization plays an important role as catheterization outside the 
sterile confines of the operating room was found to be associated with a 2-5 times 
increased risk from various prospective studies. Place of catheterization outside the 
operating room had an increased of CAUTI (OR 3.93) in this study but did not 
show a statistical significance (p value 0.079).  
 
 
This study though not a very large study has shown comparable results with other 
similar studies as shown in the table. 
 
Variable 
Platt
24 
Shapiro
40 
Johnson
41 
Tambyah
20 
Riley
42 
This 
study 
Duration of 
catheterization 
+ + - + + + 
Female Gender + - + + + + 
Diabetes + NR NR + NR + 
Place of 
catheterization outside 
Operating room 
NR + NR - NR - 
Age - - - - + + 
Catheter care violation NR + - + - + 
 
 
 
 
 
 
  
 
 
 
CONCLUSION 
 
 
 
 
 
 
 
Conclusion 
The urinary tract with an indwelling catheter is highly susceptible to infection. 
Most patients acquire CAUTI within seven days of catheterization. With more and 
more inappropriate use of antibiotics there is an increased risk of developing 
infections with resistant organisms. Prevention of CAUTI rather than cure should 
be the goal in all patients catheterized for an appropriate indication. An 
understanding of the risk factors that play a significant role in development of 
CAUTI helps in reducing the additional burden on the health care system 
especially in a developing country like ours. Simple measures as shown in this 
study like shortening the duration of catheterization, strict control of diabetes and 
sterile precautions in insertion and maintenance of indwelling catheters can help 
prevent CAUTI. Female gender is a host factor that is not alterable and hence 
catheterization in females should be done only when absolutely indicated and not 
as a convenience for nurses or the health care professional. The CDC definitions of 
CAUTI
43
 should be uniformly followed so as to have a comparable outcome for 
further studies.  
Various guidelines and studies done to prevent catheter associated urinary tract 
infections need to be reviewed.
43, 44, 45 
Research on role of antibiotic prophylaxis, 
instillation of antibiotics and other agents in the drainage bag, use of different 
perineal care agents requires further study. The overall goal should be to identify, 
educate and implement best practice measures for prevention or reducing the 
incidence of catheter associated urinary tract infections.      
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ANNEXURE: 1 
 
 
ANNEXURE: 2 
PROFORMA 
 
Name:                                                KMC/GRH                  Date: 
Age:                                             Sex:                     IP No: 
Complaints:  
Reason for catheterization:     Output monitoring 
             Urinary retention 
       Incontinence 
       Postoperative  
Past H/O                          DM                                   HT                        
                                       TB                                    COPD 
    CANCER 
General  Examination         
                          Pallor    Icterus Lymphadenopathy Edema 
                           Systemic Examination: CVS: 
      P/A: 
      R.S: 
DATE AND PLACE  OF CATHETERISATION: 
TYPE OF CATHETER USED: 
SIZE OF CATHETER: 
DRAINAGE SYSTEM: CLOSED/OPEN 
DURATION OF CATHETERIZATION: 
Post Catheterization symptoms: 
Fever  
Irritative LUTS 
Supra pubic pain 
Loin pain 
Urinary turbidity 
Investigations 
Urine  -  Albumin                                
                Sugar 
                Deposits 
HEMOGLOBIN:     
UREA 
CREATININE  
CAUTI: 
URINE C/S 
Organism Grown: 
Antibiotic sensitivity: 
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